Complete Filing Data
Medirom Healthcare Technologies Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $329.40 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Medirom Healthcare Technologies Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income * | $148.8M | $115.4M | $149.0M | -$990.7M | -$539.2M | $17.3M |
| Selling General And Administrative Expense | $2.24B | $1.96B | $1.81B | $1.82B | $1.07B | $871.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $8.30B | $6.83B | $6.95B | $5.41B | $3.34B | $3.91B |
| Other Nonoperating Income Expense | $42.9M | -$13.9M | $51.1M | $24.4M | $19.7M | $4.2M |
| Operating Income Loss | -$18.1M | -$391.6M | $97.0M | -$470.6M | -$746.1M | $34.4M |
| Nonoperating Income Expense | $65.8M | $412.2M | $82.8M | $56.1M | $119.4M | -$1.6M |
| Income Taxes Paid Net | $12.8M | $52.1M | $30.8M | $45.5M | $7.0M | $24.3M |
| Income Tax Expense Benefit | -$90.5M | -$94.4M | $30.8M | $576.3M | -$87.5M | $16.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $47.7M | $20.6M | $179.8M | -$414.5M | -$626.7M | $32.7M |
| Interest Expense | $36.9M | $9.8M | $12.0M | $13.2M | $13.6M | |
| Impairment Of Long Lived Assets Held For Use | $22.9M | $0.00 | $0.00 | $63.2M | $106.5M | $44.5M |
| Accrued Income Taxes Current | $58.6M | $14.9M | $59.9M | $40.7M | $43.2M | $17.8M |
| Cost Of Revenue | $6.05B | $5.26B | $5.05B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $933.3M | $210.9M | -$59.4M | -$208.3M | $491.3M | $600.1M | -$117.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $329.4M | $106.3M | $605.5M | $370.6M | $1.44B | $513.6M | $211.7M |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $901.2M | $931.5M | $673.5M | $917.1M | $604.7M | $749.0M | |
| Repayments Of Long Term Debt | $96.7M | $99.1M | $45.3M | $251.1M | $206.4M | $234.4M | |
| Goodwill | $389.1M | $484.6M | $539.5M | $600.3M | $150.7M | $78.3M | $64.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $223.1M | -$499.1M | $234.8M | -$1.07B | $926.1M | $301.9M | |
| Assets | $8.09B | $6.85B | $6.75B | $5.75B | $5.71B | $4.76B | |
| Cash And Cash Equivalents At Carrying Value | $2.1M | $106.3M | $605.5M | $370.6M | $1.44B | $513.6M | |
| Intangible Assets Acquired But Not Yet Paid | $93.0M | $9.5M | $14.2M | $1.5M | $3.3M | ||
| Long Term Debt Noncurrent | $764.2M | $1.05B | $1.15B | $746.6M | $668.4M | $150.5M | |
| Treasury Stock Value | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | |
| Retained Earnings Accumulated Deficit | $229.0M | $80.3M | -$2.55B | -$2.69B | -$1.70B | -$705.3M | |
| Property Plant And Equipment Net | $435.7M | $451.5M | $424.3M | $425.0M | $235.9M | $169.0M | |
| Other Liabilities Noncurrent | $17.4M | $9.8M | $30.4M | $25.2M | $7.7M | $5.6M | |
| Other Liabilities Current | $414.7M | $370.2M | $525.6M | $270.8M | $118.9M | $115.6M | |
| Other Assets Noncurrent | $80.6M | $16.7M | $13.7M | $107.2M | $79.5M | $54.5M | |
| Operating Lease Right Of Use Asset | $2.07B | $2.09B | $1.96B | $1.82B | $1.58B | $1.83B | |
| Operating Lease Liability Noncurrent | $1.29B | $1.33B | $1.21B | $1.13B | $992.9M | $1.14B | |
| Operating Lease Liability Current | $792.8M | $763.4M | $769.8M | $755.2M | $658.3M | $704.0M | |
| Nontrade Receivables Current | $646.2M | $606.1M | $789.8M | $543.0M | $411.3M | $428.3M | |
| Long Term Investments | $87.4M | $81.5M | $53.0M | $53.0M | $500.0K | $14.0M | |
| Liabilities Current | $4.18B | $3.56B | $3.64B | $3.20B | $2.65B | $2.26B | |
| Liabilities And Stockholders Equity | $8.09B | $6.85B | $6.75B | $5.75B | $5.71B | $4.76B | |
| Inventory Net | $151.6M | $140.0M | $114.1M | $18.7M | $8.0M | $5.5M | |
| Deposits Assets Noncurrent | $808.6M | $848.7M | $895.3M | $868.2M | $710.6M | $769.1M | |
| Contract With Customer Liability Noncurrent | $36.9M | $71.1M | $156.4M | $239.1M | $334.0M | $465.1M | |
| Contract With Customer Liability Current | $53.5M | $109.3M | $89.0M | $104.2M | $172.1M | $201.6M | |
| Assets Current | $2.71B | $1.76B | $2.36B | $1.38B | $2.09B | $1.38B | |
| Additional Paid In Capital Common Stock | $354.6M | $113.6M | $1.27B | $1.27B | $1.02B | $713.3M | |
| Accrued Liabilities Current | $325.5M | $1.26B | $1.38B | $865.9M | $889.1M | $448.0M | |
| Accounts Receivable Net Current | $1.36B | $621.9M | $534.7M | $312.3M | $148.5M | $337.0M | |
| Accounts Payable Current | $1.01B | $137.7M | $207.6M | $230.9M | $67.0M | $122.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Payments To Develop Software | $493.4M | $786.2M | $45.8M | $18.1M | $30.6M | $12.1M |
| Payments To Acquire Property Plant And Equipment | $71.4M | $135.8M | $120.7M | $95.7M | $73.6M | $7.4M |
| Net Cash Provided By Used In Operating Activities | -$1.33B | -$631.7M | -$685.7M | -$557.2M | -$366.4M | $7.9M |
| Net Cash Provided By Used In Investing Activities | $361.4M | -$328.6M | $580.4M | -$83.9M | -$139.6M | -$37.9M |
| Net Cash Provided By Used In Financing Activities | $1.19B | $461.2M | $340.1M | -$427.9M | $1.43B | $332.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.4M | $530.0K | $181.5M | $74.8M | $8.2M | $39.7M |
| Increase Decrease In Other Receivables | $39.2M | -$43.4M | $210.5M | $87.1M | $48.0M | $36.2M |
| Increase Decrease In Other Operating Capital Net | $82.5M | $17.8M | -$50.1M | -$5.2M | $10.9M | $9.5M |
| Increase Decrease In Other Current Liabilities | $22.7M | -$77.4M | $254.7M | $130.1M | -$3.4M | $10.2M |
| Increase Decrease In Inventories | $10.6M | $25.9M | $95.4M | $2.4M | $2.4M | -$892.0K |
| Increase Decrease In Deposit Other Assets | -$46.9M | -$46.7M | $27.2M | $70.7M | -$58.5M | $14.2M |
| Increase Decrease In Deposit | -$25.7M | -$42.7M | -$24.4M | -$46.5M | -$98.9M | -$20.9M |
| Increase Decrease In Advances | -$27.9M | -$104.7M | -$111.1M | $96.2M | -$15.3M | -$39.2M |
| Increase Decrease In Accrued Taxes Payable | $43.7M | -$45.0M | $19.2M | -$2.9M | $25.4M | $4.2M |
| Increase Decrease In Accrued Liabilities | -$1.05B | $97.0M | $517.7M | $195.5M | $206.7M | $116.9M |
| Increase Decrease In Accounts Receivable | -$339.1M | -$580.7M | $222.4M | $37.0M | -$189.1M | $66.9M |
| Increase Decrease In Accounts Payable | $876.5M | -$69.9M | -$23.3M | $58.4M | -$55.6M | -$18.7M |
| Depreciation Depletion And Amortization | $290.0M | $252.6M | $184.1M | $126.2M | $62.3M | $46.2M |
| Proceeds From Collection Of Finance Receivables Long Term | $15.2M | $11.7M | $2.6M | $9.5M | $15.0M | $16.3M |
| Increase Decrease In Contract With Customer Liability | -$90.0M | -$65.0M | -$82.6M | -$162.8M | -$160.6M | |
| Share Based Compensation | $196.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 5.1M | 4.9M | 4.9M | 4.9M | 4.0M | 3.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 5.9M | 5.2M | 5.5M | 4.9M | 4.0M | 4.3M |
| Earnings Per Share Diluted | $28.52 | $22.34 | $27.23 | $-203.13 | $-133.97 | $4.06 |
| Earnings Per Share Basic | $29.13 | $23.64 | $30.54 | $-203.13 | $-133.97 | $4.63 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Provision For Doubtful Accounts | $49.8M | $2.0M | -$36.4M | $28.8M | -$11.4M | $271.0K | |
| Investment Income Interest | $8.0K | $1.1M | $6.1M | $839.0K | $1.3M | $1.3M | |
| Investment Income Dividend | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Interest Paid Net | $47.6M | $34.6M | $7.5M | $10.9M | $10.2M | $11.9M | |
| Costs And Expenses | $8.32B | $7.22B | $6.86B | $5.88B | $4.09B | $3.87B | |
| Subsidies Income | $13.9M | $21.4M | $20.6M | $27.8M | $111.6M | ||
| Other Noncash Income Expense | -$53.1M | -$45.7M | -$819.0K | -$1.9M | $895.0K | ||
| Asset Retirement Obligations Noncurrent | $378.9M | $344.3M | $310.9M | $296.4M | $191.2M | $127.4M | $119.5M |
| Capital Expenditures Incurred But Not Yet Paid | $12.3M | $4.6M | $23.5M | $29.2M | |||
| Advances Received | $409.7M | $402.7M | $507.4M | $618.5M | $461.7M | $483.1M |
Most recent annual filing with the SEC: April 29, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.